ISMP Releases Targeted Medication Safety Best Practices for Hospitals
An ISMP report highlights drug name confusion as one of the leading causes of medication errors.
Tag Archives: Oxycontin
-
-
Johnson & Johnson Opioid Settlement May Provide $5B For States and Cities Nationwide
Johnson & Johnson has announced it is increasing its opioid crisis settlement commitment to $5 billion.
-
Lawsuit Indicates Prenatal Opioid Exposure Resulted In Severe Withdrawal Symptoms, Developmental Impacts
A class action lawsuit calls on the makers of opioids to pay for the medical care of children born addicted to their drugs.
-
Johnson & Johnson Settles Lawsuits Over Opioid Crisis Brought By Ohio Counties
Johnson & Johnson will pay $20.4 million to settle opioid crisis lawsuits brought by two Ohio counties just three weeks before a trial was set to begin.
-
OxyContin Maker Purdue Pharma Reaches Opioid Epidemic Settlement With Some States, Cities
Purdue Pharma has reportedly entered into a $12 billion tentative settlement agreement to resolve thousands of opioid crisis lawsuits filed by states and cities, which will drive the company into…
-
Opioid Crisis Settlement Structure Proposed To Resolve Thousands of Claims Nationwide
Plaintiffs involved in opioid crisis lawsuits have proposed a settlement negotiation structure which would involve every city and county within the United States.
-
Opioid Settlement Results in Agreement to Pay $270M to State of Oklahoma By Makers of Oxycontin
Oklahoma and Purdue Pharma have reached a $270 million settlement to resolve claims the company's mislead the public about the safety of OxyContin, helping to spur the national opioid crisis.
-
Oxycontin Addiction Risks Withheld by Drug Maker, Who “Created Manmade Disaster”: Lawsuit
New documents suggest Purdue Pharma aggressively pushed OxyContin prescriptions despite the risks of addiction, then called for company officials to shift the blame for the opioid crisis onto addicts and…
-
Lawsuits Over Opioid-Addicted Infants Will Not Be Consolidated in Separate MDL
The U.S. JPML has refused to create a separate multidistrict litigation for lawsuits over children suffering from neonatal abstinence syndrome caused by opioids.
-
Opioid Manufacturers Oppose Separate MDL For Infant Addiction Lawsuits
Manufacturers of opioids say they oppose the creation of a separate federal consolidated litigation for cases involving infants born addicted to opioids.
